Open AccessRandomized, Double-Blind, Multicenter Phase 2 Study to Evaluate Efficacy and Safety of Intravenous Iclaprim Versus Vancomycin in the Treatment of Hospital-Acquired, Ventilator-Associated, or Health-Care-Associated Pneumonia Suspected or Confirmed Caused by Gram-Positive Pathogens
Author(s) -
David B. Huang,
Mark Wilcox,
Paul Hadvàry,
Ralph Corey
Publication year - 2015
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofv133.608
Subject(s) - medicine , vancomycin , pneumonia , ventilator associated pneumonia , intensive care medicine , randomized controlled trial , data monitoring committee , emergency medicine , staphylococcus aureus , biology , bacteria , genetics